Phocas Financial »

BioCryst Pharmaceuticals shares owned by Phocas Financial

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Phocas Financial from 13F filings

Historical chart of Phocas Financial investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Phocas Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Phocas Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 251k 7.80

More positions owned by Phocas Financial

Wintrust Financial Corporation (WTFC)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Nexstar Media Group Common Stock (NXST)
SkyWest (SKYW)
Columbia Banking System (COLB)
Adtalem Global Ed (ATGE)
Ameris Ban (ABCB)
Stonex Group (SNEX)
Preferred Bk Los Angeles Ca Com New (PFBC)
Hecla Mining Company (HL)
Meta Financial (CASH)
MKS Instruments (MKSI)
White Mountains Insurance Gp (WTM)
TTM Technologies (TTMI)
Sanmina (SANM)

View all positions for Phocas Financial

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
Alkeon Capital Management
UBS Group
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Nuveen
Goldman Sachs Group
Jennifer Ranahan
Eversept Partners
Bnp Paribas Arbitrage, Snc

View all funds holding BioCryst Pharmaceuticals